Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of besipirdine in male patients with stress urinary incontinence after radical prostatectomy
2009-014049-10Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in stress urinary incontinence (SUI) and urinary incontinence (UI) comparing Besipirdine arm with Placebo arm (2 arms). Primary endpoints: Leakage volume at 24-hour home pad test, Patient Global Impression (PGI) of severity and 1 more. Started Oct 2009; status: completed.
02
Drugs
besipirdine
03
Conditions
stress urinary incontinence (SUI)urinary incontinence (UI)
Beyond the preview
Go deeper on 2009-014049-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014049-10.